[48]
In addition to the combined effect of the Disclosure Order, s. 6(7) and (8) of the
Regulations
and Rules 151 and 152 of the
Federal Court Rules
, Novopharm says that a comprehensive protective order should be granted on the grounds that Novopharm has met the normal test for the issuance of such orders in accordance with the Supreme Court of Canada's decision in
Sierra Club
.